Managing hepatic cirrhosis represents a multifaceted and protracted therapeutic challenge—critical to success is the accurate identification of root causes alongside the disease’s hallmark manifestations

Hepatic cirrhosis represents one of the most severe gastrointestinal disorders, defined by the irreversible replacement of functional liver tissue with fibrous scar tissue. This pathological remodeling impairs the organ’s core functions—including detoxification, protein synthesis, and coagulation factor production. Due to its insidious, often asymptomatic progression in early stages, the condition is frequently diagnosed only after complications such as portal hypertension, ascites, or hepatic encephalopathy have developed.

The cornerstone of effective therapeutic management lies in the precise identification of the underlying etiologic factor. In cases of alcoholic cirrhosis, complete and sustained abstinence is mandatory, supplemented by psychological counseling and pharmacologic support to mitigate withdrawal symptoms. For viral cirrhosis, the implementation of targeted antiviral regimens is critical to decelerate—or even halt—disease progression. In both scenarios, continuous monitoring of hepatic biochemical markers and adherence to a specialized diet—high in plant-based protein and low in sodium—are essential components of care.

In advanced stages, when liver failure ensues, orthotopic liver transplantation may emerge as the sole life-saving intervention. However, given the scarcity of donor organs and stringent eligibility criteria, patients require comprehensive multidisciplinary care involving hepatologists, dietitians, psychologists, and palliative medicine specialists. Early detection and intervention significantly enhance prognostic outcomes, underscoring the necessity of routine screening among high-risk populations, including individuals with alcohol dependence or chronic hepatitis virus carriage.